94 results
8-K
EX-99.1
NOTV
Inotiv Inc
22 Jan 14
Regulation FD Disclosure
12:00am
globally
Confidential and Proprietary What differentiates us? 10 Innovation Regulatory Excellence Customer Focus
Confidential and Proprietary … Innovation - Services Problem: A m ethod requires specialty handling or unique study designs which are not the core competency of the larger CROs. Solution
8-K
EX-99.1
NOTV
Inotiv Inc
20 Jan 15
NOBLE FINANCIAL CAPITAL MARKETS 11 TH ANNUAL INVESTOR CONFERENCE Jacqueline M. Lemke President & CEO January 2015
12:00am
market potential
MARKET FOCUSED INNOVATIVE Innovation in CRO Services Flexible – Creative - Custom Built a relationship of trust, challenge and continuous … tenfold » improved sensitivity by close to 40% . » reduced analysis time 27 to 7 minutes » Drug is now in Phase 3 trials. Innovation in CRO Services
8-K
EX-99.2
NOTV
Inotiv Inc
5 Nov 21
Inotiv, Inc. Shareholders Approve Acquisition of Envigo
5:17pm
clients
with a unique, full-spectrum discovery-to-approval solution to meet the increasing growth and innovation in biopharma and demand for specialty
8-K
EX-99.1
NOTV
Inotiv Inc
21 Sep 21
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
9:53am
basis.
“Evolving complexity in the disease research space is creating additional demand for research models, and continued innovation in biopharma
8-K
EX-99.1
NOTV
Inotiv Inc
29 Dec 14
BASi Reports Fourth Quarter and Full Year 2014 Results
12:00am
for innovation and regulatory excellence to leverage our costs and attain greater profits, while driving growth by delivering enhanced customer value
FWP
0cwca1z
18 Mar 11
Free writing prospectus
12:00am
8-K
EX-99.1
llyzhv9b
9 Mar 21
Company Presentation March 2021
6:06am
8-K
EX-99.2
ib0cwp9gqhw08gm595
21 Sep 21
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
9:53am
10-K
12nmqa6 0aiwioomi05l
24 Dec 98
Annual report
12:00am
424B3
y9kniaywvf0njkbtd611
20 Jan 15
Prospectus supplement
12:00am